Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.
JAMA
; 327(2): 179-181, 2022 01 11.
Article
in English
| MEDLINE | ID: covidwho-1653102
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Antibodies, Neutralizing
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
Type of study:
Diagnostic study
/
Randomized controlled trials
Topics:
Vaccines
/
Variants
Limits:
Humans
Language:
English
Journal:
JAMA
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS